Burke Steven Keith 4
4 · Akebia Therapeutics, Inc. · Filed May 18, 2023
Insider Transaction Report
Form 4
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2023-05-16$1.07/sh−63,567$67,890→ 530,487 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted "sell-to-cover" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on May 12, 2022.